VOR Stock Analysis: Buy, Sell, or Hold?
VOR - Vor Biopharma Inc. Common Stock
$12.79
0.00 (0.00%)
▲
5d:
-13.35%
30d:
+9.88%
90d:
-46.95%
WAIT
LOW Confidence
Last Updated: February 2, 2026
Earnings: Mar 19, 2026
Get Alerted When VOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called VOR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VOR is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VOR is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VOR is currently trading at $12.79, which is considered slightly low relative to its 30-day fair value range of $12.30 to $15.94.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $12.35, while resistance sits at $18.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $44.60 (+248.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $12.35, while resistance sits at $18.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $44.60 (+248.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$12.30 -
$15.94
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 248.7% below Wall St target ($44.60)
- WARNING: Recommendation downgraded due to -13.3% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$12.30 -
$15.94
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$12.35
Resistance Level
$18.60
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.78
Wall Street Target
$44.60
(+248.7%)
Last updated: February 03, 2026 9:09 AM ET
Data refreshes hourly during market hours. Next update: 10:09 AM
Data refreshes hourly during market hours. Next update: 10:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Reprogrammed Interchange…
SELL
200 shares
2025-10-21
Ra Capital Management, L…
SELL
25027 shares
2025-10-21
Reprogrammed Interchange…
SELL
11616 shares
2025-10-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
